A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

NCT03357731 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Cardiac Failure
Reduced Ventricular Ejection Fraction

Interventions

DRUG: HNO Donor
DRUG: Nitroglycerin (NTG)
OTHER: Placebo

Sponsor

Bristol-Myers Squibb